LLP

In the new SPAC ruling, the court questions the basic structure of SPACs under Delaware law | Skadden, Arps, Slate, Meagher & Flom LLP

With all the SPAC activity and scrutiny over the past few years, it was only a matter of time before Delaware courts had the opportunity to get involved in a SPAC shareholder dispute. Early last year, in January 2022, Vice Chancellor Lori Will of the Delaware Court of Chancery issued a groundbreaking opinion in Litigation …

In the new SPAC ruling, the court questions the basic structure of SPACs under Delaware law | Skadden, Arps, Slate, Meagher & Flom LLP Read More »

Show Me Crypto: England’s High Court Issues New Information Orders Against Crypto Exchanges | Shearman & Sterling LLP

The High Court has once again grappled with new issues arising from crypto-asset disputes, this time in the context of an interim request for information orders.[1] The Plaintiff (“LMN”), a company incorporated in England and Wales and a cryptocurrency exchange operator, allegedly lost millions of dollars in cryptocurrency during a hacker attack. After conducting a …

Show Me Crypto: England’s High Court Issues New Information Orders Against Crypto Exchanges | Shearman & Sterling LLP Read More »

SEC Releases Guidance on Disclosure Obligations Related to Crypto Asset Markets | Balch & Bingham LLP

On December 8, 2022, the Division of Corporate Finance within the Securities and Exchange Commission (“SEC”) published guidance on disclosure obligations related to recent disruptions in the crypto asset market. A sample letter to companies regarding recent developments in the crypto asset markets aims to improve compliance with disclosure obligations under SEC regulations. Federal law …

SEC Releases Guidance on Disclosure Obligations Related to Crypto Asset Markets | Balch & Bingham LLP Read More »

Spectrum Pharmaceuticals, Inc. (SPPI) Shareholder Alert: Robbins LLP Reminds Investors of Deadline for Lead Plaintiff in Class Action Against Spectrum Pharmaceuticals, Inc.

SAN DIEGO–(BUSINESS WIRE)–Class: Robbins LLP reminds investors that a stockholder has filed a class action lawsuit on behalf of all purchasers of Spectrum Pharmaceuticals, Inc. common stock. (NASDAQ: SPPI) between December 6, 2021 and September 22, 2022 for violating the Securities Exchange Act of 1934. Spectrum is a biopharmaceutical company focused on the acquisition, development …

Spectrum Pharmaceuticals, Inc. (SPPI) Shareholder Alert: Robbins LLP Reminds Investors of Deadline for Lead Plaintiff in Class Action Against Spectrum Pharmaceuticals, Inc. Read More »